| IPI00513827 - ACADM, PUTATIVE UNCHARACTERIZED PROTEIN DKFZP686M24262. | |
|---|---|
| Uniprot Accession: Q5T4U5 | |
| Uniprot ID: Q5T4U5_HUMAN | |
| Mapping: Chr 1, 75962624 - 76001952 | |
| Entrez Gene: 34 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_2939) |
|---|
| Rat: Acadm, MEDIUM-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE, MITOCHONDRIAL PRECURSOR. |
| Mouse: Acadm, MEDIUM-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE, MITOCHONDRIAL PRECURSOR. |
| Mouse: Acadm, MEDIUM-CHAIN ACYL-COA DEHYDROGENASE (FRAGMENT). |
| Human: ACADM, MEDIUM-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE, MITOCHONDRIAL PRECURSOR. |
| Human: ACADM, PUTATIVE UNCHARACTERIZED PROTEIN DKFZP686M24262. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| mitochondrial matrix | C | IEP | ISS ISS | |
| mitochondrion | C | TAS | IDA | TAS ISS ISS IEA |
| acyl-CoA dehydrogenase activity | F | IMP IEA | IEA IEA | IDA ISS ISS ISS |
| FAD binding | F | IEA | IEA | IEA |
| isomerase activity | F | IDA | ||
| oxidoreductase activity, acting on the CH-CH group of donors | F | IEA | ||
| oxidoreductase activity | F | IEA | ||
| response to glucocorticoid stimulus | P | IEP | ||
| electron transport | P | IEA | IEA | IEA |
| response to copper ion | P | IEP | ||
| response to nutrient | P | IEP | ||
| fatty acid metabolic process | P | IEA | IEA | ISS IEA |
| lipid metabolic process | P | IEA | IEA | IEA |
| metabolic process | P | IEA | IEA | IEA |
| response to drug | P | IEP | ||
| response to hormone stimulus | P | IEP | ||
| fatty acid beta-oxidation | P | IMP | TAS ISS ISS |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| homeostasis/metabolism phenotype | MP | Un | ||
| lethality-postnatal | MP | Un | ||
| muscle phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un | ||
| liver/biliary system phenotype | MP | Un |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| fatty acid metabolic pathway | W | IEA | ||
| beta-alanine metabolic pathway | W | IEA | ||
| valine, leucine and isoleucine degradation pathway | W | IEA | ||
| propanoate metabolic pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| beta-Alanine metabolism (00410) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Propanoate metabolism (00640) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Fatty acid metabolism (00071) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| PPAR signaling pathway (03320) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Valine, leucine and isoleucine degradation (00280) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |